Market
  • Company Info.

    GlaxoSmithKline Pharmaceuticals Ltd.

    Shareholding Pattern



    Market Cap.(`) 34611.35 Cr. P/BV 19.86 Book Value (`) 102.89
    52 Week High/Low ( ` ) 2524/1243 FV/ML 10/1 P/E(X) 56.12
    Book Closure 30/06/2023 EPS (`) 36.41 Div Yield (%) 1.57
    You can view the shareholding pattern for the latest two quarters for the company under two broad categories (Promoter & Non Promters).

    •  

    Shareholding Pattern as on 31/03/2024
    Summary statement holding of specified securities
    Category of shareholder Nos. of shareholders No. of fully paid up equity shares held Total nos. shares held Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2) Shareholding as a % assuming full conversion of convertible securities (as a percentage of diluted share capital) As a % of (A+B+C2) Number of equity shares held in dematerialized form
    (A) Promoter & Promoter Group 4 127054524 127054524 75.00 75.00 127054524
    (B) Public 118990 42351510 42351510 25.00 25.00 40934381
    (C1) Shares underlying DRs 0 0 0 0.00 0.00 0
    (C2) Shares held by Employee Trust 0 0 0 0.00 0.00 0
    (C) Non Promoter-Non Public 0 0 0 0.00 0.00 0
    Grand Total 118994 169406034 169406034 100.00 100.00 167988905

    Category of shareholder Nos. of shareholders No. of fully paid up equity shares held No. of shares underlying Depository Receipts Total nos. shares held Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2) Number of equity shares held in dematerialized form
    Shareholding of Promoter and Promoter Group
    Foreign
    Any Others (Specify) 4 127054524 0 127054524 75.00 127054524
    GLAXO GROUP LIMITED 1 60970500 0 60970500 35.99 60970500
    GLAXOSMITHKLINE PTE LIMITED 1 47604024 0 47604024 28.10 47604024
    ESKAYLAB LIMITED 1 11760000 0 11760000 6.94 11760000
    BURROUGHS WELLCOME INTERNATIONAL LIMITED 1 6720000 0 6720000 3.97 6720000
    Grand Total4127054524012705452475.00127054524
    Public Shareholding
    Institutions
    Mutual Funds 33 7636512 0 7636512 4.51 7623092
    ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C 1 1711233 0 1711233 1.01 1711233
    Insurance Companies 13 5498517 0 5498517 3.25 5498517
    LICI ASM NON PAR 1 3278114 0 3278114 1.94 3278114
    Alternate Investment Funds 6 210707 0 210707 0.12 210707
    NBFCs registered with RBI 8 1988 0 1988 0.00 1988
    Banks 18 18240 0 18240 0.01 11276
    Foreign Portfolio Investors Category I 162 5576847 0 5576847 3.29 5576847
    Other Financial Institutions 5 12984 0 12984 0.01 0
    Foreign Portfolio Investors Category II 12 314262 0 314262 0.19 314262
    Other Foreign Institutions 4 1899 0 1899 0.00 1861
    BANKS 3 1849 0 1849 0.00 1811
    FOREIGN INSTITUTIONAL INVESTORS 1 50 0 50 0.00 50
    Sub Total2611927195601927195611.3819238550
    Non-Institutions
    Any Others (Specify) 2329 546352 0 546352 0.32 546352
    HUF 2299 419020 0 419020 0.25 419020
    Trusts 27 126977 0 126977 0.07 126977
    Clearing Members 3 355 0 355 0.00 355
    Bodies Corporate 916 1641058 0 1641058 0.97 1622076
    Resident Individuals holding nominal share capital up to Rs. 2 lakhs 112124 18248724 0 18248724 10.77 16893184
    Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs 18 847188 0 847188 0.50 847188
    Non Resident Indians (NRIs) 3333 808903 0 808903 0.48 799702
    Investor Education and Protection Fund (IEPF) 1 985907 0 985907 0.58 985907
    Directors and their relatives (excluding independent directors and nominee directors) 1 600 0 600 0.00 600
    Foreign Nationals 5 728 0 728 0.00 728
    Sub Total1187272307946002307946013.6221695737
    Central Government / State Government(s) / President of India
    State Government / Governor 1 50 0 50 0.00 50
    Shareholding by Companies or Bodies Corporate where Central / State Government is a promoter 1 44 0 44 0.00 44
    Sub Total2940940.0094
    Grand Total1189904235151004235151025.0040934381
  • GlaxoSmithKline Pharmaceuticals Ltd.

    Products & Raw Material



    Market Cap.(`) 34611.35 Cr. P/BV 19.86 Book Value (`) 102.89
    52 Week High/Low ( ` ) 2524/1243 FV/ML 10/1 P/E(X) 56.12
    Book Closure 30/06/2023 EPS (`) 36.41 Div Yield (%) 1.57

    You can view the entire product & raw materials mix with Product names, Sales quantity & Value along with percentage contribution from each individual product.

    Product Report
    Product NameYearMonthSales QuantityUOMSales Value (` Crs.)Product Mix (%)
    Pharmaceuticals2023120.00-3,181.4098.91
    Service Income2023120.00-24.850.77
    Other Operating Revenue2023120.00-10.090.31
    Raw Material Report
    Product NameYear/MonthSales QuantityUOMSales Value (` Crs)Product Mix (%)
    Raw Materials23/030.00Not Reported394.35100.00
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html